Complementary Prognostic Value of ALBI Grade and Child–Pugh Classification in HCC Treated With SBRT

<h3>Background/Aim:</h3> Accurate assessment of liver function is essential for selecting patients with hepatocellular carcinoma (HCC) undergoing stereotactic body radiotherapy (SBRT). In this study, we examined whether the albumin–bilirubin (ALBI) grade and the Child–Pugh classification provide independent prognostic information when modeled concurrently. <h3>Patients and Methods:</h3> A retrospective analysis was conducted on 102 patients with HCC who received initial SBRT (2013-2020) and were classified as ALBI grades 1-2 and Child–Pugh classes A-B. Both classifications were entered simultaneously into a multivariable Cox proportional hazards model adjusted for age, sex, viral hepatitis status, time since HCC diagnosis, and prior local treatments. Model discrimination was evaluated using the concordance index (C-index) and the Akaike information criterion (AIC). <h3>Results:</h3> The median follow-up was 52 months, and the median overall survival (OS) was 71 months. In the multivariable analysis, both ALBI grade 2 [hazard ratio (HR)=2.20; 95%confidence interval (CI)=1.07-4.51; <i>p</i>=0.032] and Child–Pugh class B (HR=3.70; 95%CI=1.77-7.72; <i>p</i>&lt;0.001) were independently associated with poorer OS. The combined model incorporating both classifications showed improved discrimination compared with either classification alone (C-index, 0.7283 <i>vs</i>. 0.6976 and 0.7104; ΔAIC ≥2.85), indicating a complementary prognostic value. ALBI grade worsening at six months identified nonclassic radiation-induced liver disease in 21.5% of patients <i>versus</i> 7.5% identified by a ≥2-point increase in the Child–Pugh score, with 90% nonoverlap between criteria. <h3>Conclusion:</h3> ALBI grade 2 and Child–Pugh class B were independently associated with OS, with neither exhibiting clear superiority. Their combined use – ALBI grade for objective biochemical stratification and Child–Pugh for clinical assessment incorporating ascites and encephalopathy – may provide a more comprehensive evaluation than either system alone.

Authors

Institutions

Publication Details

Journal
Anticancer Research
Published
2026-06-29
DOI
https://doi.org/10.21873/anticanres.18256
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Complementary Prognostic Value of ALBI Grade and Child–Pugh Classification in HCC Treated With SBRT

Yasuhide Motoyoshi, Ryo Toya, Atsumasa Komori, Shinya Nagaoka et al.
Anticancer Research
Hepatocellular Carcinoma Treatment and Prognosis
article

Complementary Prognostic Value of ALBI Grade and Child–Pugh Classification in HCC Treated With SBRT

Yasuhide Motoyoshi, Ryo Toya, Atsumasa Komori, Shinya Nagaoka, DAISUKE NAKAMURA
article en

Abstract

<h3>Background/Aim:</h3> Accurate assessment of liver function is essential for selecting patients with hepatocellular carcinoma (HCC) undergoing stereotactic body radiotherapy (SBRT). In this study, we examined whether the albumin–bilirubin (ALBI) grade and the Child–Pugh classification provide independent prognostic information when modeled concurrently. <h3>Patients and Methods:</h3> A retrospective analysis was conducted on 102 patients with HCC who received initial SBRT (2013-2020) and were classified as ALBI grades 1-2 and Child–Pugh classes A-B. Both classifications were entered simultaneously into a multivariable Cox proportional hazards model adjusted for age, sex, viral hepatitis status, time since HCC diagnosis, and prior local treatments. Model discrimination was evaluated using the concordance index (C-index) and the Akaike information criterion (AIC). <h3>Results:</h3> The median follow-up was 52 months, and the median overall survival (OS) was 71 months. In the multivariable analysis, both ALBI grade 2 [hazard ratio (HR)=2.20; 95%confidence interval (CI)=1.07-4.51; <i>p</i>=0.032] and Child–Pugh class B (HR=3.70; 95%CI=1.77-7.72; <i>p</i>&lt;0.001) were independently associated with poorer OS. The combined model incorporating both classifications showed improved discrimination compared with either classification alone (C-index, 0.7283 <i>vs</i>. 0.6976 and 0.7104; ΔAIC ≥2.85), indicating a complementary prognostic value. ALBI grade worsening at six months identified nonclassic radiation-induced liver disease in 21.5% of patients <i>versus</i> 7.5% identified by a ≥2-point increase in the Child–Pugh score, with 90% nonoverlap between criteria. <h3>Conclusion:</h3> ALBI grade 2 and Child–Pugh class B were independently associated with OS, with neither exhibiting clear superiority. Their combined use – ALBI grade for objective biochemical stratification and Child–Pugh for clinical assessment incorporating ascites and encephalopathy – may provide a more comprehensive evaluation than either system alone.

Anticancer ResearchVol. 46(7)
University of Nagasaki (JP), Nagasaki Medical Center (JP), Nagasaki University (JP)
Reduced inequalities
Openalex Percentile: Top 8%
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.